Catalog No.
EHJ95501
Expression system
Mammalian Cells
Species
Homo sapiens (Human)
Protein length
Gln26-Leu322
Predicted molecular weight
35.17 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
Q8N743
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution.A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
CD158z, Killer cell immunoglobulin-like receptor 3DL3, CD158Z, CD158 antigen-like family member Z, Killer cell inhibitory receptor 1, KIR3DL3, KIRC1, KIR3DL7
Analysis of KIR and HLA Polymorphism in Chinese Individuals With COVID-19., PMID:39364548
Characterisation of novel KIR alleles: KIR3DL3*0070105, KIR3DL3*0130202, KIR3DL1*0080104 and KIR3DL1*0010121., PMID:39291308
Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells., PMID:37390222
Characterization of the novel KIR3DL3*116 allele identified in a Chinese Han individual., PMID:37157941
Identification of the novel KIR3DL3*118 allele in a Chinese Han individual., PMID:37157939
The novel KIR3DL3*117 allele identified by sequencing-based typing in a Chinese Han individual., PMID:37143306
HHLA2 immune-regulatory roles in cancer., PMID:37011487
Protocol for evaluating antitumor activity of KIR3DL3 blockade in an NK cell-based xenogeneic lung tumor model., PMID:36386885
KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy., PMID:35933091
KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target., PMID:34244312
KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1., PMID:33229411
[Identification of a novel KIR3DL3*064 allele by cDNA cloning and sequencing]., PMID:32761604
Regulation of KIR3DL3 Expression via Mirna., PMID:31405037
Conservation, Extensive Heterozygosity, and Convergence of Signaling Potential All Indicate a Critical Role for KIR3DL3 in Higher Primates., PMID:30745901
Targeted resequencing of candidate genes reveals novel variants associated with severe Behçet's uveitis., PMID:24136464
Extensive variation in gene copy number at the killer immunoglobulin-like receptor locus in humans., PMID:23840750
The distribution of genetic diversity of KIR genes in the Chinese Mongolian population., PMID:22836038
Conserved KIR allele-level haplotypes are altered by microvariation in individuals with European ancestry., PMID:21796155
The characteristics of allelic polymorphism in killer-immunoglobulin-like receptor framework genes in African Americans., PMID:21607693
Killer cell immunoglobulin-like receptor genes in patients with breast cancer., PMID:21479698
Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes., PMID:20580654
Seventeen novel alleles add to the already extensive KIR3DL3 diversity., PMID:17900289
For research use only. Not for human or drug use.
